Global Generic Drugs Strategic Research Report 2023-2030 - Increasing Demand for Biosimilars, Driven by Patent Expiry of Major Biopharmaceutical Drugs
April 16, 2024 10:08 ET
|
Research and Markets
Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "Generic Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Generic Drugs Market to Reach...
Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
April 01, 2024 07:00 ET
|
Sol-Gel Technologies Ltd.
Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
Global Inhalation and Nasal Spray Generic Drugs Research Report 2024: Asthma Treatment Takes the Lead, Bronchodilators Dominates the Market - Forecasts to 2034
January 31, 2024 09:50 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Inhalation And Nasal Spray Generic Drugs Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's...
Global Generic Drugs Market Report 2024 - Historical Revenue Data for 2020-2022, Estimates for 2023 and CAGR Projections Through 2028
January 26, 2024 04:03 ET
|
Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Global Markets for Generic Drugs" report has been added to ResearchAndMarkets.com's offering. The global market for generic drugs was valued at...
Global Generic Drugs Strategic Business Report 2023: Market to Reach $671.5 Billion by 2030 - U.S. Market is Estimated at $122.8 Billion, While China is Forecast to Grow at 8.2% CAGR
October 20, 2023 06:03 ET
|
Research and Markets
Dublin, Oct. 20, 2023 (GLOBE NEWSWIRE) -- The "Generic Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Generic Drugs Market to Reach...
Berkshire Sterile achieves its first commercial drug approval by the FDA
March 22, 2022 10:00 ET
|
Berkshire Sterile Manufacturing
Lee, MA, March 22, 2022 (GLOBE NEWSWIRE) -- On March 1, 2022, a long-term client of Berkshire Sterile Manufacturing (BSM) announced the FDA approval of their Abbreviated New Drug Application (ANDA)...
AMRN INVESTOR NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Amarin Corporation plc Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AMRN
December 02, 2021 19:45 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 02, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Amarin Corporation plc (NASDAQ: AMRN) between December 5,...
ROSEN, A LONGSTANDING LAW FIRM, Encourages Amarin Corporation plc Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AMRN
October 29, 2021 17:34 ET
|
The Rosen Law Firm PA
NEW YORK, Oct. 29, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Amarin...
Global $650+ Billion Generic Drugs Market to 2025: Competitive Landscape, Trends, Structure, Recent Mergers and Acquisitions, Brand Name Company Involvement
May 31, 2021 06:48 ET
|
Research and Markets
Dublin, May 31, 2021 (GLOBE NEWSWIRE) -- The "Global Generic Drugs Market 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global market for generic drugs should grow...
Jubilant Receives Favorable Rulings from the U.S. Patent Office Invalidating Bracco Rubidium-Infusion-System Patents
February 17, 2020 08:00 ET
|
Jubilant Pharma
YARDLEY, Pa., Feb. 17, 2020 (GLOBE NEWSWIRE) -- On February 7, 2020, Jubilant DraxImage Inc., and certain of its affiliates (“Jubilant”) were informed by the U.S. Patent Office that it agreed with...